Akero Therapeutics, Inc. Long-Term Debt, Maturity, Year Three
Akero Therapeutics, Inc. had Long-Term Debt, Maturity, Year Three of $7.22 million as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree · last filed 2025-08-08
- 2025-06-30: Long-Term Debt, Maturity, Year Three $7.22M.
- 2025-03-31: Long-Term Debt, Maturity, Year Three $7.22M.
- 2024-12-31: Long-Term Debt, Maturity, Year Three $7.22M; Long-Term Debt, Maturity, Year Three as first filed $27.78M.
- 2024-09-30: Long-Term Debt, Maturity, Year Three $7.34M.
| Period end | Long-Term Debt, Maturity, Year Three | Long-Term Debt, Maturity, Year Three as first filed |
|---|---|---|
| 2025-06-30 | $7.22M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $7.22M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $7.22M 10-Q · filed 2025-08-08 | $27.78M 10-K · filed 2025-02-28 |
| 2024-09-30 | $7.34M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $7.47M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $7.47M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $16.12M 10-K · filed 2025-02-28 | $7.34M 10-K · filed 2024-02-29 |
| 2023-09-30 | $10.49M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $10.47M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $10.46M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $3.73M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $3.74M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $3.76M 10-Q · filed 2022-08-05 |